Treffen zwischen Vertretern der Bundesregierung und des Unternehmens Eli Lilly and Company

This procedure concerns a written question asked to the German government regarding a meeting with representatives from the pharmaceutical company Eli Lilly and Company. The question likely seeks details about the discussions held, potential policy implications, and the government's engagement with the pharmaceutical industry.